Drugs of the 21st century: telithromycin (HMR 3647) - the first ketolide

被引:92
作者
Ackermann, G [1 ]
Rodloff, AC [1 ]
机构
[1] Univ Leipzig, Inst Med Microbiol & Epidemiol Infect Dis, D-04103 Leipzig, Germany
关键词
new antimicrobials; telithromycin; resistance;
D O I
10.1093/jac/dkg123
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Telithromycin (HMR 3647) is the first ketolide introduced into clinical practice. Ketolides are semisynthetic derivates of erythromycin A that carry novel biological properties on the erythronolide A ring. This new class of antimicrobials was designed to overcome current resistance mechanisms against erythromycin A within Gram-positive cocci. Ketolides do not induce macrolide-lincosamide-streptogramin B (MLSB) resistance and are active against erythromycin resistance methylase gene (erm)-carrying Gram-positive cocci. This review summarizes published data on telithromycin and intends to define the challenge that a new antimicrobial brings to medical practice.
引用
收藏
页码:497 / 511
页数:15
相关论文
共 104 条
[21]  
BRYSKIER A, 2002, MIL DRUG TH, P97
[22]  
BUCHANAN P, 2001, 41 INT C ANT AG CHEM, P461
[23]   Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000 [J].
Cantón, R ;
Loza, E ;
Morosini, MI ;
Baquero, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 :9-24
[24]  
CARBON C, 2000, 40 INT C ANT AG CHEM, P490
[25]   Inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by 11 different ketolide antibiotics [J].
Champney, WS ;
Tober, CL .
CURRENT MICROBIOLOGY, 1998, 37 (06) :418-425
[26]  
Champney WS, 2001, CURR MICROBIOL, V42, P203
[27]   Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes [J].
Clancy, J ;
Petitpas, J ;
DibHajj, F ;
Yuan, W ;
Cronan, M ;
Kamath, AV ;
Bergeron, J ;
Retsema, JA .
MOLECULAR MICROBIOLOGY, 1996, 22 (05) :867-879
[28]   Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice [J].
Consigny, S ;
Bentoucha, A ;
Bonnafous, P ;
Grosset, J ;
Ji, BH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) :2919-2921
[29]  
CRAIG WA, 2001, 41 INT C ANT AG CHEM, P34
[30]  
CUNDLIFFE E, 1990, RIBOSOME, P479